Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy
- 31 July 1995
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 127 (1) , 151-153
- https://doi.org/10.1016/s0022-3476(95)70277-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infantsActa Obstetricia et Gynecologica Scandinavica, 1993
- Utility of glucagon in the emergency departmentThe Journal of Emergency Medicine, 1993
- Neonatal adaptation in hypertensive pregnancy — A study of labetalol vs hydralazine treatmentjpme, 1993
- Fetal death following labetalol administration in pre‐eclampsiaActa Obstetricia et Gynecologica Scandinavica, 1992
- Hypertensive Drugs in PregnancyClinics in Perinatology, 1991
- Severe Adverse Effects of Maternal Labetalol in a Premature InfantActa Paediatrica, 1989
- The use of labetalol for attenuation of the hypertensive response to endotracheal incubation in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1988
- The effect of maternal labetalol on the newborn infantBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Side effects of labetalol in newborn infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1983